Share
Market Research Report

BILE DUCT CANCER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Treatment TypeChemotherapy (Gemcitabine, Cisplatin, Oxaliplatin, Capecitabine, 5 fluorouracil (5-FU)) · Targeted Therapy ( Pemigatinib, Infigratinib (Phase 3), Ivosidenib (Phase 3)) · Immunotherapy (Pembrolizumab (Phase 3)) · Others
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · Online Pharmacies
  • By GeographyNorth America · Latin America · Asia Pacific · Europe · Middle East · and Africa
  • Published In03 Apr 2026
  • Report CodeCMI4790
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Treatment Type
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Scenario
    • Acquisitions and Partnerships Scenario
    • Funding and Investments
    • PEST Analysis
    • Porter’s Analysis
  4. Global Bile Duct Cancer Market, By Treatment Type, 2021 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Chemotherapy
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
        • Gemcitabine
        • Cisplatin
        • Oxaliplatin
        • Capecitabine
        • 5 fluorouracil (5-FU)
    • Targeted Therapy
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
        • Pemigatinib
        • Infigratinib (Phase 3)
        • Ivosidenib (Phase 3)
    • Immunotherapy
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
        • (Pembrolizumab (Phase 3)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  5. Global Bile Duct Cancer Market, By Distribution Channel, 2021 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospital Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Retail Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Online Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  6. Global Bile Duct Cancer Market, By Region, 2021 – 2033, (USD Bn)

    • Introduction

      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Region, 2022–2033
      • Regional Trends
    • North America

      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America

      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe

      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific

      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East

      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa

      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape

    • Company Profiles
      • F. Hoffmann-La Roche Ltd
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Sanofi
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Pfizer Inc.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Bristol-Myers Squibb Company
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Eli Lilly and Company
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Merck & Co., Inc.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Novartis AG
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Celgene Corporation
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Johnson & Johnson Services, Inc.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Teva Pharmaceutical Industries Ltd.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Bayer AG
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Fresenius Kabi AG
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Mylan N.V.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • ConMed Corporation
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Boston Scientific Corporation
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Taiho Pharmaceutical Co., Ltd.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Incyte Corporation
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
  8. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
    • References and Research Methodology

    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 28 figures on "Bile Duct Cancer Market” - Global forecast to 2033